Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome

Figure 3 Double-labeling immunofluorescence of leptin and tryptase in irritable bowel syndrome patients and healthy controls. A: Colonic mucosal double-labeling immunofluorescence of leptin and tryptase in IBS-D patients (× 400, arrows represent colocalization of leptin and tryptase); B: Colonic mucosal double-labeling immunofluorescence of leptin and tryptase in healthy controls (× 400, arrows represent colocalization of leptin and tryptase). IBS-D: Iirritable bowel syndrome with diarrhea.